致命芬太尼:一片即可致死
2016年3月下旬8天内,18例患者因服用街头购得的氢可酮/对乙酰氨基酚片后出现 exaggerated 阿片毒性就诊。1例院内死亡,5例接受心肺复苏,1例需体外生命支持,3例插管,2例球囊面罩通气。17/18例需纳洛酮推注,4例需延长纳洛酮输注(26–39小时);1例在停用纳洛酮8小时后毒性复发。18例血清芬太尼均阳性,13例定量为7.9–162 ng/mL(均值52.9 ng/mL),药片含芬太尼600–6,900 μg/片。该暴发对急诊科和ICU资源造成压力。
要点
- 街头购得的氢可酮/对乙酰氨基酚片可能实为芬太尼掺假片,外观和重量与正品片几乎无法区分。
- 18例中17例需纳洛酮推注,4例需延长纳洛酮输注26–39小时,提示需要更高剂量和更长疗程。
- 1例在停用纳洛酮8小时后毒性复发,提示停药后观察期需延长。
- 18例中1例院内死亡,5例接受心肺复苏,1例需体外生命支持,3例插管,2例球囊面罩通气。
- 13例血清芬太尼定量为7.9–162 ng/mL(均值52.9 ng/mL),药片含芬太尼600–6,900 μg/片。
适用人群与场景
- 2016年3月下旬8天内因服用街头购得的氢可酮/对乙酰氨基酚片后出现 exaggerated 阿片毒性而就诊于本机构的患者,共18例。
处置流程与药物剂量
- 17/18例患者需要纳洛酮推注。
- 4例患者需要延长纳洛酮输注,持续26–39小时。
- 1例患者在停用纳洛酮8小时后出现毒性复发,需延长停用纳洛酮后的观察期。
红旗征与不能漏的情况
- 服用街头购得的氢可酮/对乙酰氨基酚片后出现比预期更明显的阿片毒性症状,需警惕芬太尼掺假。
- 停用纳洛酮后8小时可发生毒性复发,需延长观察。
研究设计与关键结果
- 研究类型为暴发调查;2016年3月下旬8天内共18例患者因 exaggerated 阿片毒性就诊于本机构。
- 18例中1例院内死亡;5例接受心肺复苏,1例需体外生命支持,3例需插管,2例接受球囊面罩通气。
- 17/18例需要纳洛酮推注,4例需要延长纳洛酮输注(26–39小时);1例在停用纳洛酮8小时后毒性复发。
- 18例血清芬太尼均阳性;13例血清定量芬太尼浓度为7.9–162 ng/mL(均值52.9 ng/mL)。
- 药片分析显示芬太尼含量为600–6,900 μg/片,药片外观与正品氢可酮/对乙酰氨基酚片几乎无法区分且重量相似。
- 截至报告时,该县已报告56例芬太尼阿片毒性病例,其中15例死亡。
证据类型、等级与局限
- 证据类型:暴发调查(病例系列)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对服用街头购得氢可酮/对乙酰氨基酚片后出现 exaggerated 阿片毒性的患者,应考虑到芬太尼掺假可能。
- 此类患者可能需要更高剂量和更长时间的纳洛酮输注,并延长停用纳洛酮后的观察期。
- 芬太尼掺假片外观与正品氢可酮/对乙酰氨基酚片几乎无法区分,不能仅凭外观排除。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: The current national opioid epidemic is a public health emergency. We have identified an outbreak of exaggerated opioid toxicity caused by fentanyl adulterated tablets purchased on the street as hydrocodone/acetaminophen.
METHODS: Over an 8-day period in late March 2016, a total of 18 patients presented to our institution with exaggerated opioid toxicity. The patients provided a similar history: ingesting their "normal dose" of hydrocodone/acetaminophen tablets but with more pronounced symptoms. Toxicology testing and analysis was performed on serum, urine, and surrendered pills.
RESULTS: One of the 18 patients died in hospital. Five patients underwent cardiopulmonary resuscitation, one required extracorporeal life support, three required intubation, and two received bag-valve-mask ventilation. One patient had recurrence of toxicity after 8 hours after naloxone discontinuation. Seventeen of 18 patients required boluses of naloxone, and four required prolonged naloxone infusions (26-39 hours). All 18 patients tested positive for fentanyl in the serum. Quantitative assays conducted in 13 of the sera revealed fentanyl concentrations of 7.9 to 162 ng/mL (mean = 52.9 ng/mL). Pill analysis revealed fentanyl amounts of 600-6,900 μg/pill. The pills are virtually indistinguishable from authentic hydrocodone/acetaminophen tablets and are similar in weight. To date, our county has reported 56 cases of fentanyl opioid toxicity, with 15 fatalities. In our institution, the outbreak has stressed the capabilities and resources of the emergency department and intensive care units.
CONCLUSIONS: A serious outbreak of exaggerated opioid toxicity caused by fentanyl-adulterated tablets purchased on the street as hydrocodone/acetaminophen is under way in California. These patients required higher dosing and prolonged infusions of naloxone. Additionally, observation periods off naloxone were extended due to delayed, recurrent toxicity. The outbreak has serious ramifications for public health and safety, law enforcement, and healthcare facilities and resources.
参考来源
- Sutter ME, Gerona RR, Davis MT, et al. Fatal Fentanyl: One Pill Can Kill. Acad Emerg Med. 2016. PMID: 27322591. doi:10.1111/acem.13034
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。